Ambey Laboratories Limited — QIP/Rights/Pref., 27-06-2025: Preferential issue

Ambey Laboratories has announced a board meeting to approve an increase in authorized share capital to Rs 37 Cr and amend its Articles of Association to allow issuance of warrants and convertible securities. The company plans a preferential issue of up to 1.08 crore warrants convertible into equity shares at Rs 46 each (face value Rs 10), aiming to raise nearly Rs 50 Cr. Fifteen investors, including promoters and institutional entities, are participating. Warrants can be converted into equity within 18 months. Proceeds are likely intended for growth and strengthening the capital base.